Well, "using the more conservative estimate of the 12-month MMR rate for imatinib, the upper bound of the 95th percentile confidence interval...is 34%" so, worse-case, we may need to hit 49%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.